National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
FEBS Lett. 2010 Oct 22;584(20):4330-4. doi: 10.1016/j.febslet.2010.09.027. Epub 2010 Sep 23.
Recent studies have demonstrated that FoxO1 modulates the expression of SREBP-1c, but the exact mechanism remains unknown. Our results demonstrate that FoxO1 suppresses the SREBP-1c promoter transcriptional activity in HepG2 cells. This repression was independent of FoxO1 binding to the SREBP-1c promoter, but LXR responsive elements (LXREs) were crucial to this phenomenon. Moreover, FoxO1 also strongly inhibited the LXRα-mediated elevated transcription by SREBP-1c promoter. Electrophoretic mobility shift assay and chromatin immuno-precipitation further suggested the ability of FoxO1 to inhibit LXRα binding with the LXRE in the SREBP-1c promoter. FoxO1-mediated suppression of SREBP-1c promoter activity could be partially alleviated by insulin.
最近的研究表明,FoxO1 调节 SREBP-1c 的表达,但确切的机制尚不清楚。我们的结果表明,FoxO1 抑制 HepG2 细胞中 SREBP-1c 启动子的转录活性。这种抑制作用不依赖于 FoxO1 与 SREBP-1c 启动子的结合,但 LXR 反应元件 (LXRE) 对此现象至关重要。此外,FoxO1 还强烈抑制了 LXRα 介导的 SREBP-1c 启动子转录的升高。电泳迁移率变动分析和染色质免疫沉淀进一步表明,FoxO1 能够抑制 LXRα 与 SREBP-1c 启动子中的 LXRE 结合。FoxO1 介导的 SREBP-1c 启动子活性的抑制作用可部分被胰岛素缓解。